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Introduction
Cell migration is crucial for many biological events, including
embryonic development, tissue morphogenesis, inflammation,
wound healing and tumor metastasis (Gumbiner, 1996; Hanahan
and Weinberg, 2000; Madri and Graesser, 2000; Martin, 1997).
Migration is a complex process requiring dynamic cytoskeletal
reorganization and regulated interplay between cell attachment
and detachment. The process consists of four phases: adhesion,
spreading, contraction and tail retraction. Adhesion is dependent
on matrix density, integrin density and integrin activation.
Spreading requires focal complex formation, actin
polymerization, Cdc42-dependent filopodia formation and
Rac1-dependent lamellipodia formation (Ridley et al., 1992).
Contraction occurs when traction forces are transmitted through
integrin and actin-myosin cytoskeleton interactions, and involves
Rho-dependent stress fiber and focal contact (or focal adhesion)
formation (Ridley and Hall, 1992). Finally, tail retraction
requires integrin release from the extracellular matrix and
cytoskeleton, and might be the rate-limiting step in cell
migration (Palecek et al., 1996).
A significant advance in our understanding of cytoskeletal
dynamics is the realization that members of the formin
(Fmn)/diaphanous (Dia) family of proteins [here collectively
referred to as formin-homology (FH) proteins] have crucial
roles in actin cytoskeleton reorganization. FH proteins
are evolutionarily conserved and regulate cytokinesis and
cell polarity in Drosophila melanogaster, Saccharomyces
cerevisiae, Schizosaccharomyces pombe and Aspergillus
nidulans (Afshar et al., 2000; Castrillon and Wasserman, 1994;
Chang et al., 1997; Harris et al., 1997; Kohno et al., 1996).
They also regulate conjugation in S. pombe (Petersen et al.,
1995) and axial and bud site selection in S. cerevisiae
(Evangelista et al., 1997; Imamura et al., 1997; Zahner et al.,
1996). Recently, it was demonstrated that FH proteins in
S. cerevisiae induce actin cable formation in an Arp2/3-
independent manner prior to tropomyosin stabilization
(Evangelista et al., 2002; Sagot et al., 2002) and are nucleators
of unbranched and polarized actin filaments (Pruyne et al.,
2002).
In mammalian cells, FH proteins regulate cytoskeletal
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Formin-homology-domain-containing proteins interact
with Rho-family GTPases and regulate actin cytoskeleton
organization and gene transcription. FHOD1 is a member
of this family, interacts with Rac1 and induces
transcription from the serum response element. In this
study, we examined the effects of FHOD1 expression on
cytoskeletal organization and function in mammalian
cells. FHOD1 proteins were stably expressed in WM35
melanoma cells and NIH-3T3 fibroblasts. Cells expressing
full-length FHOD1 demonstrated an elongated phenotype
compared with vector-transfected cells and cells expressing
a truncated FHOD1 (1-421) that lacks the conserved FH1
and FH2 domains. Full-length FHOD1 co-localized with
filamentous actin at cell peripheries. Cells transiently
expressing a C-terminal FHOD1 truncation mutant (D C,
residues 1-1010), which lacks an autoinhibitory protein-
protein interaction domain, displayed prominent stress
fibers. FHOD1 (1-421) did not induce stress fibers but
localized to membrane ruffles in a manner similar to the
full-length protein, indicating that the FH1 and FH2
domains are required for stress fiber appearance. FHOD1
D C (1-1010)-dependent stress fibers were sensitive to
dominant-negative RacN17 and the RhoA and ROCK
inhibitors, C3 transferase and Y-27632. Stable
overexpression of full-length FHOD1 enhanced the
migration of WM35 and NIH-3T3 cells to type-I collagen
and fibronectin, respectively. Cells expressing FHOD1 (1-
421) migrated similar to control cells. Integrin expression
and activation were not affected by FHOD1 expression.
Moreover, FHOD1 overexpression did not alter integrin
usage during adhesion or migration. These data
demonstrate that FHOD1 interacts with and regulates the
structure of the cytoskeleton and stimulates cell migration
in an integrin-independent manner.
Key words: Formin homology, FHOD1, Actin cytoskeleton, Stress
fibers, Migration, Cell motility, FHOS
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organization, embryonic patterning, cell survival, migration
and gene transcription (Habas et al., 2001; Ishizaki et al., 2001;
Jackson-Grusby et al., 1992; Sotiropoulos et al., 1999;
Tominaga et al., 2000; Trumpp et al., 1992; Watanabe et al.,
1997; Watanabe et al., 1999; Westendorf, 2001; Yayoshi-
Yamamoto et al., 2000). Fmn mutations cause limb deformities
and renal failure in mice (Maas et al., 1990; Woychik et al.,
1985; Woychik et al., 1990; Wynshaw-Boris et al., 1997). In
humans, Dia mutations are linked with autosomal dominant
deafness (Dia1) and premature ovarian failure (Dia2) (Bione
et al., 1998; Lynch et al., 1997). Increased Dia2 expression is
also directly associated with the metastatic potential of rat
osteosarcoma cells (Fukuda et al., 1999). Thus, deregulated FH
protein activity in mammalian cells causes developmental
defects and might contribute to cancer progression.
FH proteins regulate these diverse processes by interacting
with actin binding proteins and bridging Rho-family GTPases
to Src tyrosine kinase and Wnt signaling pathways
(Evangelista et al., 1997; Habas et al., 2001; Ishizaki et al.,
2001; Kohno et al., 1996; Tominaga et al., 2000; Watanabe et
al., 1997; Watanabe et al., 1999; Yayoshi-Yamamoto et al.,
2000). Increasing evidence suggests that FH proteins play a
crucial role in cell motility processes. A truncated, active form
of the RhoA effector mDia1 is sufficient to restore force-
induced focal contact formation in cells containing inactive
RhoA, thereby suggesting that mDia is crucial for cell
contraction (Riveline et al., 2001). Expression of a truncated
version of mDia1 containing the Rho-binding domain inhibits
the directed migration of CHO cells in a wound closure assay
(Krebs et al., 2001). Similarly, expression of a truncated form
of formin-related gene in leukocytes (FRL) containing the
Rac1-binding domain inhibits cell spreading and chemokine-
induced migration of an FRL-expressing macrophage cell line
by blocking cell adhesion to fibronectin (Yayoshi-Yamamoto
et al., 2000). Thus, FH proteins appear to regulate several
stages of cell migration.
FHOD1 (formin-homology-2-domain-containing protein)
is an FH protein that was previously described as FHOS
(Westendorf, 2001; Westendorf et al., 1999). Its designation
was changed to meet the Guidelines for Human Gene
Nomenclature. FHOD1 is a characteristic FH family member
in that it contains a GTPase binding domain (GBD), FH1
and FH2 domains, a coiled coil, and a Diaphanous-like
autoregulatory domain (DAD) (Alberts, 2000; Wasserman,
1998). FHOD1 interacts with Rac1 in a guanine-nucleotide-
independent manner (Westendorf, 2001). Self-interactions
between the N- and C-termini prevent full-length FHOD1 from
activating gene transcription from the serum response element
(SRE). However, deletion of the N- or C-termini allows
FHOD1 to induce SRE transcription (Westendorf, 2001). The
induction of the SRE by the C-terminal FHOD1 mutant,
FHOD1 D C, was independent of Rac1 (Westendorf, 2001). The
goals of this study were to determine the effects of FHOD1 and
FHOD1 C-terminal truncation mutations on cell behavior and
actin cytoskeleton organization. FHOD1 and FHOD1 D C co-
localized with F-actin at the cell periphery and in newly formed
stress fibers, respectively. FHOD1 expression also induced cell
elongation and enhanced the migration of WM35 melanoma
cells and NIH-3T3 fibroblasts to extracellular matrix
components without affecting integrin usage. These data show
that expression of a full-length FH protein affects cell motility
and suggest that FH proteins are crucial regulators of cell
migration.
Materials and Methods
FHOD1 plasmids, retroviruses and antibodies
pCMV5-HA-FHOD1 expression plasmids have been described
previously (Westendorf, 2001). pMSCV-HA-FHOD1 plasmids were
generated by subcloning hemagglutinin (HA) epitope-tagged FHOD1
cDNAs from pCMV5 plasmids into pMSCV via the Gateway cloning
system (Invitrogen, Carlsbad, CA). This vector drives expression of
FHOD1 from the murine stem cell virus (MSCV) long terminal repeat.
Downstream of the FHOD1 cDNA, an internal ribosomal entry site
drives the expression of enhanced green fluorescent protein (eGFP).
FHOD1 retroviruses were generated by co-transfecting 293T cells with
20 m g pMSCV and 20 m g pCl2 (Naviaux et al., 1996; Norris et al.,
1998) plasmids by calcium phosphate precipitation. Supernatants were
harvested at 24 hours and 48 hours, and filtered through a 0.45 m m
syringe filter. Aliquots of the viral supernatants were stored at –80°C.
FHOD1-N rabbit antiserum was generated by Rockland
Laboratories (Gilbertsville, PA) using glutathione-S-transferase
(GST)-FHOD1 (1-328) fusion protein as an immunogen. FHOD1-C
mouse antiserum have been described previously (Westendorf et al.,
1999).
Generation of stable cells lines
WM35 and NIH-3T3 cells were transduced twice within 24 hours
with retroviral supernatants in the presence of 8 m g ml–1 polybrene.
eGFP expression was monitored by immunofluorescence microscopy.
2-3 days after the last transduction, eGFP-positive cells were selected
by fluorescence-activated cell sorting on a FACSVantage flow
cytometer (Becton Dickinson, Mountain View, CA). WM35 cells
were maintained in DMEM supplemented with 10% fetal bovine
serum (Biowhittaker, East Rutherford, NJ), 2 mM L-glutamine, 50 U
ml–1 penicillin and 50 m g ml–1 streptomycin. NIH-3T3 cells were
maintained in DMEM supplemented with 10% bovine calf serum
(Biowhittaker), 2 mM L-glutamine, 50 U ml–1 penicillin and 50 m g
ml–1 streptomycin. FHOD1 and eGFP levels were regularly monitored
with immunoblotting and microscopy, respectively. Robert Kerbel
(University of Toronto, Canada) generously provided the WM35
melanoma cells.
Cell measurements
Digital phase contrast images were imported into NIH-Image, where
cell lengths and widths were measured in arbitrary units. Length-to-
width ratios were calculated for each cell. Isolated cells (20-34) in a
minimum of three fields were measured for each cell line. Statistical
significance was determined with a one-way analysis of variance.
In situ immunofluorescence analysis
NIH-3T3 cells were grown on coverslips and transfected with
expression vectors encoding HA-tagged wild-type or truncated
FHOD1 proteins. Cells were washed with phosphate buffered saline
(PBS) 24 hours after transfection and fixed with 4% paraformaldehyde
for 5 minutes at room temperature. Cells were washed three times with
PBS prior to blocking and permeabilization with 0.2% Triton X-100
in 5% normal goat serum in PBS for 30 minutes. For assays of F-actin
and FHOD1 co-localization, coverslips were sequentially incubated for
30 minutes with phalloidin-rhodamine (1 U per coverslip; Molecular
Probes, Eugene, OR) followed by a 1 hour incubation with rabbit anti-
HA antibody (1:400, Santa Cruz Biotechnology, Santa Cruz, CA) and
1 hour incubation with fluorescein isothiocyanate (FITC)-conjugated
goat anti-rabbit antibody (1:400; Jackson ImmunoResearch
Laboratories, West Grove, PA).
Journal of Cell Science 116 (9)
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For RacN17 experiments, NIH-3T3 cells were transiently
transfected with pCMV5-FHOD1 D C and pCMV-T7-Rac N17. 24
hours after transfection, cells were washed in PBS and fixed with 4%
paraformaldehyde (pH 7.1) in PBS for 5 minutes at room temperature
prior to washing and blocking in 5% normal goat serum in PBS. For
Rho pathway inhibition experiments, cells were exposed for 18 hours
to C3 transferase (Rho inhibitor) or for 10 hours to Y-27632 (ROCK
inhibitor). Cells were washed in cytoskeleton buffer (CB; 10 mM
MES, 150 mM NaCl, 5 mM EGTA, 5 mM MgCl2, 5 mM glucose, pH
6.1) and fixed in 3% paraformaldehyde in CB for 10 minutes at room
temperature. Cell were subsequently washed with CB, 0.1% Triton X-
100 in CB for 1 minute prior to washing and blocking in 5% normal
goat serum in PBS. For assays of F-actin and FHOD1 co-localization,
coverslips were sequentially incubated for 30 minutes with phalloidin-
rhodamine (1 U per coverslip; Molecular Probes) in PBS, followed
by a 1 hour incubation with rabbit anti-HA antibody (1:400; Santa
Cruz) and a 1 hour incubation with FITC-conjugated goat anti-rabbit
antibody (1:400; Jackson ImmunoResearch Laboratories). Between
and after antibody incubations, coverslips were washed in PBS and
then mounted on glass slides in Vectashield mounting medium (Vector
Laboratories, Burlingame, CA) and visualized at 400 · or 600· using
a Nikon confocal microscope. For assays of FHOD1 D C, RacN17 and
F-actin co-localization, the above protocols were followed except that
incubation with anti-HA antibody was followed by washing and a 1
hour incubation with mouse anti-T7 antibody (1:1000; Novagen,
Madison, WI). Secondary antibodies were Cy5-labeled donkey anti-
rabbit and FITC-labeled goat anti-mouse antibodies (Jackson
ImmunoResearch Laboratories).
Immunoprecipitations
HEK293T cells were transfected with HA-tagged FHOD1 plasmids
or empty vector (pCMV5) by calcium phosphate precipitation. 24
hours after transfection, the plates were placed on liquid nitrogen for
1 minute and 1 ml lysis buffer (50 mM HEPES pH 7.8, 1% Triton X-
100, 1 mM EDTA, 30 mM sodium pyrophosphate, 1 mM sodium
vanadate, 10 mM sodium fluoride, 1 m M phenylmethylsulfonyl
fluoride, 20 ng ml–1 aprotinin) was added. Lysates were vortexed and
centrifuged to pellet detergent-insoluble cell debris. Protein
concentrations of lysates were determined using the BCA Protein
Assay (Pierce, Rockford, IL). Equal amounts of protein were
incubated for 2 hours with gentle rocking at 4°C with antibodies
specific for HA (Covance, Berkeley, CA) or actin (Santa Cruz).
Protein-A/Sepharose beads (Amersham Biosciences, Inc., Piscataway,
NJ) were added for 20 minutes with gentle rocking at 4°C. Immune
complexes were collected by centrifugation, washed twice with lysis
buffer supplemented with 0.1% sodium dodecyl sulfate and then
washed twice with 50 mM HEPES prior to the addition of 1 · sample
buffer. Proteins from immunoprecipitations or whole cell extracts
were resolved by 8-12% SDS-PAGE, electrophoretically transferred
to polyvinyldifluoride (PVDF; Schleicher & Schuell, Keene, NH) or
nitrocellulose membranes (Amersham Pharmacia Biotech) and
immunoblotted with primary antibodies for HA or actin, followed by
the appropriate secondary antibodies. Proteins on PVDF membranes
were detected using alkaline-phosphatase-conjugated secondary
antibodies in a colorimetric reaction. Nitrocellulose membranes
were developed with horseradish-peroxidase-conjugated secondary
antibodies using the enhanced chemiluminescence system
(Amersham Pharmacia Biotech).
Flow cytometry
Transduced WM35 cells were detached with 3 mM EDTA in PBS and
washed in fluorescence buffer [1 · PBS, 2.5% bovine calf serum
(BCS)]. Cells (3· 105) were incubated with 5 m g ml–1 of the indicated
primary monoclonal antibody (mAb) for 30 minutes on ice. The cells
were washed once with fluorescence buffer and then incubated for 30
minutes on ice with 5 m g ml–1 secondary antibodies conjugated to
phycoerytherin or Cy5 (Jackson ImmunoResearch Laboratories).
After two washes, the cells were resuspended in 1%
paraformaldehyde and analyzed on FACScalibur flow cytometer.
Mean fluorescence intensities of eGFP positive cells were determined
using CELLQuest software (Becton Dickinson). Antibodies
recognizing integrins a 1, a 3, a 4, b 4 and a Vb 3 were purchased from
Chemicon (Temecula, CA). Anti-a 2 and 9EG7 b 1 mAbs were
purchased from Pharmingen (San Diego, CA). Tucker LeBien and
Yoji Shimizu (University of Minnesota, Minneapolis, MN) kindly
provided the P5D2 and 15/7 b 1 Abs, respectively. Control mouse and
rat antibodies were obtained from Cappell (Cochranville, PA).
Cell adhesion assays
Immulon 1B 96-well plates (Dynex Technologies, Chantilly, VA)
were coated overnight on ice with 100 m l of rat-tail type-I collagen
(Becton Dickinson) at the indicated concentrations. Wells were
blocked with PBS containing 3% (w/v) bovine serum albumin (BSA)
for 1 hour at 37°C. Cells were released with 3 mM EDTA, washed
twice in serum-free medium containing 20 mM HEPES, pH 7.1
(SFM/HEPES) and 1% BSA (w/v) and then resuspended to 1 · 105
cells ml–1 in the same medium. For integrin-blocking assays, cells
were suspended in SFM/HEPES to 1 · 106 cells ml–1, pre-incubated
with 2.5 m g ml–1 of the indicated mAb for 15 minutes at 37°C and
then diluted to 1 · 105 cells ml–1. Cells (1 · 104 in 100 m l) were added
to the plates and allowed to adhere to the wells for 20 minutes at 37°C.
Wells were washed twice with SFM/HEPES containing 1% BSA and
then twice with SFM/HEPES. Growth medium [DMEM containing
10% fetal bovine serum (FBS); 100 m l] was added to the wells.
PMS/MTS solution (CellTiter96 Aqueous Non-radioactive Cell
Proliferation Assay, Promega, Madison, WI) was then added
according to the manufacturer’s instructions (20 m l per well). Cells
were incubated at 37°C for 3-4 hours. Absorbance at 490 nm was
measured with an ELISA plate reader. The number of adherent cells
was determined by normalizing to a standard curve generated with
increasing volumes of the starting cell dilutions. Values represent the
mean of triplicate samples.
Cell migration assays
Migration assays were performed in a modified Boyden chamber
(NeuroProbe, Gaithersburg, MD). Cells were detached with 3 mM
EDTA in PBS and washed in SFM/HEPES. Ligands [rat-tail type-I
collagen, mouse type-IV collagen (Invitrogen), purified human
plasma fibronectin, mouse laminin (Invitrogen) or BSA (Sigma)] were
diluted in SFM/HEPES and added (33 m l) to the lower wells.
SFM/HEPES was placed in control wells. Cells (2.2 · 104 in 55 m l)
were placed in the upper wells and separated from the lower wells by
polycarbonate filter with 8 m m pores (Osmonics, Minnetonka, MN).
For antibody inhibition studies, cells were pretreated with 2.5 m g ml–1
of the indicated integrin or isotype-matched control antibody (in
SFM/HEPES) for 15 minutes at 37°C with rotation prior to placement
in the migration chamber. Antibodies to b 1 integrin were added at 1
m g ml–1 as this was determined to be optimal in titration experiments
(data not shown). Migration assays were incubated at 37°C for 4-5
hours. Filters were fixed and stained with Diff-Quik solutions (Dade
Behring, Newark, DE), and unmigrated cells were wiped from the
filters. Filters were mounted on glass slides in immersion oil, and
migrated cells in five random fields were counted at 400 ·
magnification.
Results
FHOD1 induces cell elongation
FHOD1 is an FH domain-containing protein that was
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previously shown to interact with the Rac1 GTPase and to
stimulate transcription from the SRE (Westendorf, 2001;
Westendorf et al., 1999). To gain a better understanding of its
cellular function, we attempted to generate stable cell lines
expressing HA-epitope-tagged full-length FHOD1 (residues
1-1165) and truncation mutants, FHOD1 D C (1-1010) and
FHOD1 (1-421) (Fig. 1A). The human melanoma cell line
WM35 and murine NIH-3T3 fibroblasts were chosen for these
studies because they expressed no detectable endogenous
FHOD1 (Fig. 1B). Cells were transduced with murine stem cell
retroviruses that express HA-FHOD1 proteins from the MSCV
long terminal repeat and eGFP from an internal ribosomal
entry site. 3-5 days after transduction, cells were selected by
fluorescence-activated cell sorting for eGFP expression. 5-7
days later, FHOD1 expression was analyzed by immunoblot
analysis with HA- or FHOD1-specific antibodies. Full-length
FHOD1 and FHOD1 (1-421) were detected in both NIH-3T3
and WM35 cells (Fig. 1B). However, FHOD1 D C expression
was never detected in sorted eGFP positive cell lines, although
it was present 2 days after transduction and prior to cell sorting
(data not shown). Thus, our construct was functional but
FHOD1 D C was not tolerated long-term in cell cultures. Cells
transduced with the full-length FHOD1 or FHOD1 (1-421)
retroviruses continued to express eGFP and the
FHOD1 protein for over 1 month in culture.
Importantly, both full-length FHOD1 and
FHOD1 (1-421) demonstrated similar
localization to membrane extensions and to the
perinuclear region (Fig. 1C). These results
suggest that the first 421 residues play a role in
targeting FHOD1 to specific subcellular locales.
An alteration in cellular morphology was
observed in eGFP-positive (i.e. post-sort)
populations expressing full-length FHOD1. NIH-3T3 (Fig.
2A) and WM35 (data not shown) cells that expressed FHOD1
were elongated in both confluent and subconfluent conditions.
These observations were quantified by measuring the lengths
and widths of subconfluent eGFP-positive NIH-3T3 cells in
phase contrast images using NIH-Image software. The length-
to-width ratio was calculated for each cell (Fig. 2B). As would
be expected for unsynchronized cell populations, wide ranges
were observed. Cells transduced with viruses expressing just
eGFP (MSCV control) or truncated FHOD1 (1-421) had a
mean length-to-width ratios of 13.7 and 13.1, respectively.
The median value for each of these populations was 10.6.
Cells expressing full-length FHOD1 displayed larger range of
values with significantly different means of 20.2 (P<0.05).
Thus, FHOD1-expressing cell populations contained
elongated cells.
FHOD1 proteins co-localize with F-actin structures
Cell shape is regulated by the actin cytoskeleton. To determine
whether FHOD1 proteins interact with and/or affect the actin
cytoskeleton, NIH-3T3 cells were transiently transfected with
FHOD1 expression constructs. In situ immunofluorescence
microscopy revealed that full-length FHOD1 was expressed in
perinuclear regions and at cell peripheries (Fig. 3A), which is
consistent with previously reported results (Westendorf, 2001).
FHOD1-expressing cells had noticeably more bundled F-actin,
as detected with rhodamine-conjugated phalloidin and
confocal microscopy, than adjacent nontransfected cells.
FHOD1 co-localized with F-actin at the cell periphery;
however, FHOD1 did not co-localize with F-actin in
perinuclear regions. Moreover, dense F-actin structures away
from the membrane did not appear to contain FHOD1. These
data indicate that FHOD1 induces or stabilizes F-actin
Journal of Cell Science 116 (9)
Fig. 1. Generation of stable FHOD1-positive WM35
and NIH-3T3 cell lines. (A) Schematic representation
of the HA-FHOD1 proteins used in these studies.
(B) Immunoblot analysis of endogenous and ectopic
FHOD1 proteins in NIH-3T3 and WM35 cells.
Protein lysates from untransduced and MSCV-
transduced cells were resolved by SDS-PAGE.
Antibodies recognizing the FHOD1 N-terminus
(FHOD1-N) were used to probe NIH-3T3 cells for
endogenous and ectopic FHOD1 proteins. WM35
cell lysates were probed with anti-HA or FHOD1-C
antibodies to detect ectopic and endogenous proteins,
respectively. (C) HA-FHOD1 protein subcellular
localization in WM35 cells. WM35 cells were grown
on coverslips and FHOD1 proteins were detected by
in situ immunofluorescence with anti-HA antisera.
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formation but that interactions between FHOD1 and F-actin
are only present at the cell periphery.
We previously demonstrated that N- and C-terminal domains
in FHOD1 mediate an intramolecular interaction(s)
(Westendorf, 2001). Deletion of the self-interaction domains
creates active FHOD1 proteins that stimulate transcription
via alternative signaling pathways. Differential cellular
localization of the FHOD1 mutants appears to be responsible
for these effects (Westendorf, 2001). To expand these studies,
we examined how FHOD1 truncation mutants interact with the
actin cytoskeleton. Cells expressing FHOD1 D C demonstrated
markedly thick stress fibers. FHOD1 D C co-localized with the
stress fibers (Fig. 3A, Fig. 4B). Cells expressing FHOD1 (1-
421) did not display stress fibers but, like cells containing
full-length FHOD1, appeared to have more F-actin than
untransfected cells in the same field. FHOD1 (1-421) also co-
localized with F-actin at the cell membrane and in the
perinuclear region. These results indicate that the N-terminus
of FHOD1 is sufficient for localization to the membrane and
perinucleus. These results demonstrate that an activated form
of FHOD1 induces or stabilizes stress fiber formation.
To determine whether FHOD1 proteins also interact with
globular (G) actin, HEK293T cells were transiently transfected
with full-length or truncated HA-FHOD1 proteins and assayed
by immunoprecipitation and immunoblotting analysis. Full-
length FHOD1 co-immunoprecipitated with Triton X-100
soluble actin (Fig. 3B). However, the truncation mutants,
FHOD1 (1-421), [1-1010 ( D C)] and (469-1165), did not
interact with G-actin. These results suggest that FHOD1
associates with G-actin and that multiple regions of FHOD1
contribute to the interaction.
FHOD1- D C-dependent stress fibers require Rac1, RhoA
and ROCK activities
We previously demonstrated that FHOD1 interacts with Rac1
but not RhoA (Westendorf, 2001). To determine whether Rac1
is required for FHOD1- D C-dependent stress fiber formation,
we transiently co-transfected NIH-3T3 cells with FHOD1 D C
and dominant-negative RacN17. Actin stress fiber organization
in cells expressing both FHOD1 D C and RacN17 was similar
to neighboring, non-transfected cells that displayed normal
actin-rich lamellipodia (Fig. 4A). Thus, RacN17 prevented the
appearance of stress fibers in FHOD1 D C-expressing cells.
These data suggest that FHOD1 is upstream of Rac1.
We also tested the effects of RhoA and ROCK inhibitors, C3
transferase and Y-27632, on FHOD1-dependent stress fibers.
Stress fiber formation requires RhoA and its downstream
effector ROCK (Amano et al., 1997; Leung et al., 1996; Ridley
and Hall, 1992). C3 transferase (Rho inhibitor; Fig. 4B) and Y-
27632 (ROCK inhibitor; Fig. 4C) inhibited FHOD1- D C-
dependent stress fibers. These inhibitors induced a phenotype
seen with Rho inhibition by RhoGAP (Tatsis et al., 1998;
Vincent and Settleman, 1999). Together these data demonstrate
that FHOD1-dependent stress fibers required Rac1, RhoA and
ROCK enzymatic activities.
FHOD1 enhances cell migration without affecting
adhesion, integrin usage or integrin activation
The altered morphology of FHOD1-expressing cells suggested
that FHOD1 might affect cell adhesion and/or motility. To
determine whether FHOD1 affects cell adhesion, transduced
WM35 cells were allowed to adhere to various concentrations
of type-I collagen. The number of adherent cells increased in
a type-I collagen concentration-dependent manner and peaked
at 15 m g ml–1 (Fig. 5A). FHOD1-expressing cells bound to
the substrate similar to control (empty pMSCV vector) and
FHOD1 (1-421)-positive cells. Likewise, the adherence of
FHOD1-positive and control NIH-3T3 cells to fibronectin was
comparable (Fig. 5B). These data indicate that FHOD1 does
not affect the overall adherence of cells to these extracellular
matrix proteins.
Although cell adhesion was not affected by FHOD1
expression, motility towards extracellular matrix proteins was
significantly enhanced in both WM35 and NIH-3T3. An
approximate two- to threefold increase in the migration of
FHOD1-positive WM35 melanoma cells to type-I collagen was
observed (Fig. 6A). Migration was concentration dependent,
but FHOD1-positive cells had increased migration at each
Fig. 2. FHOD1 induces cell elongation. (A) Fluorescent (left) and
phase contrast (right) images of transduced and sorted NIH-3T3 cells
showing the cell morphology of eGFP-expressing cells. Because the
same vector encodes FHOD1 and eGFP, eGFP expression is used as
a marker to detect FHOD1-expressing cells. (B) FHOD1-positive cell
populations contain elongated cells. The length-to-width ratios of
eGFP positive cells are plotted in the graph. The table indicates the
mean and median values for the indicated population. *P<0.05 for
FHOD1 versus MSCV and FHOD1 (1-421) cells.
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concentration relative to control (MSCV) and FHOD1 (1-421)-
expressing cells. WM35 cells did not migrate to BSA or
fibronectin (data not shown).
FHOD1-positive NIH-3T3 cells also displayed
increased migration to extracellular matrix
proteins. FHOD1-expressing cells had increased
migration to fibronectin and laminin compared
with control (MSCV) and FHOD1 (1-421)-
expressing cells (Fig. 6B). Similar results were
observed when 10% BCS, which contains
fibronectin and laminin along with other
stimulatory molecules, was used as a migratory
signal. None of the NIH-3T3 cells migrated in
response to BSA (Fig. 6B), or type-I or type-IV
collagen (data not shown). Together, these data
indicate that FHOD1 expression enhances cell
migration in both fibroblasts and melanoma cells.
To begin to understand the mechanism of
FHOD1-enhanced cell migration, we examined
integrin expression levels and the adhesion
properties of FHOD1-expressing and control
WM35 melanoma cell lines. WM35 cells
expressed a 1, a 2, a 3, a 4, b 1 and a Vb 3 at varying
levels. FHOD1-positive cells had slightly elevated
integrin levels as compared to control (MSCV) and
FHOD1 (1-421)-expressing cells (Fig. 7A) but the
mean fluorescence intensities varied by less than
10%.
To determine whether FHOD1 expression
affected integrin function in adhesion and
migration, we preincubated control (MSCV) and
FHOD1-positive WM35 cells with anti-integrin
blocking antibodies prior to placing them in
adhesion and migration assays. The a 1b 1, a 2b 1,
a 3b 1 and a Vb 3 integrins mediate binding to type-I
collagen (van der Flier and Sonnenberg, 2001).
These integrin subunits were all expressed in the
WM35 cells (Fig. 7A). Blocking antibodies to b 1
integrin completely inhibited the adhesion and
migration of control (MSCV) and FHOD1-positive
cells (Fig. 7B,C). Blocking antibodies to a 1 and a 2
each partially blocked adhesion and migration of
control (MSCV) and FHOD1-expressing WM35
cells. Antibodies blocking a 3 (Fig. 7B,C) and a Vb 3
(data not shown) did not block the adhesion or
migration of any WM35 cell populations. Thus, WM35 cell
adhesion to type-I collagen is largely mediated by a 1b 1 and
a 2b 1 integrin complexes. Importantly, FHOD1 expression did
Journal of Cell Science 116 (9)
Fig. 3. FHOD1 interacts with F-actin and G-actin.
(A) NIH-3T3 cells were transiently transfected with
plasmids encoding full-length HA-FHOD1 (1-1165),
HA-FHOD1 D C (1-1010) or HA-FHOD1 (1-421).
FHOD1 expression was detected by in situ staining with
anti-HA followed by FITC-conjugated secondary
antibodies. Cells were countered stained with
phalloidin-rhodamine to detect F-actin. Images were
collected by confocal microscopy. (B) HEK293T cells
were transiently transfected with expression vectors for
the indicated HA-FHOD1 proteins. Triton X-100
soluble cellular proteins were immunoprecipitated with
anti-HA or anti-actin antibodies. Proteins were detected
by immunoblotting with anti-HA or anti-actin
antibodies and enhanced chemiluminescence.
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not alter the ability of these integrins to mediate cell adhesion
or migration. FHOD1 also did not affect the appearance of
activation-dependent b 1 integrin conformation epitopes, 15/7
(Yednock et al., 1995) or 9EG7 (Lenter et al., 1993), in WM35
cells (Fig. 8). Divalent cations (MnCl2) increased these
epitopes to similar levels in both MSCV- and FHOD1-
expressing WM35 (data not shown). These data indicate that
FHOD1 does not affect the avidity or affinity of integrins.
Thus, FHOD1 probably enhances cell migration by activating
events downstream of integrins.
Discussion
Cell migration is required for embryonic and organ
development, inflammatory responses and wound healing.
Enhanced cell motility or metastasis is also a hallmark of
aggressive tumor cells and is associated with
poor prognosis. Cell motility requires local
filament polymerization at the leading edge of
the cell. This occurs in response to extracellular
stimuli and is mediated largely by Rho-family
GTPases through downstream effector
molecules. FH-domain-containing proteins are
one class of Rho family effectors that regulate
cytoskeleton structure. In this report, we show
that the Rac1-interacting FH protein FHOD1
enhanced cell motility to extracellular matrix
proteins in an integrin-independent manner
when expressed in fibroblasts and melanoma
cells. FHOD1 co-localized with F-actin at the
cell periphery. These data suggest a mechanism
for enhanced cell migration in which FHOD1
plays a role in F-actin formation and/or
stabilization of the leading edge.
Together with previous reports, our data
indicate that FH proteins might affect multiple
phases of cell migration. Truncated active forms
of mDia1 that lack the N-terminal RhoA-binding
domain restore force-induced focal contact
formation in cells in which RhoA is inactivated,
suggesting that mDia is crucial for cell
contraction and acts downstream of RhoA
(Riveline et al., 2001). Krebs and colleagues demonstrated that
expression of a truncated version of mDia1 containing the FH3
domain and GBD inhibits the directed cell migration of CHO
cells in a wound closure assay (Krebs et al., 2001). Third, a
truncated form of FRL containing the FH3 and Rac1-binding
domains inhibits cell spreading and chemokine-induced
migration of an FRL-expressing macrophage cell line by
blocking cell adhesion to fibronectin (Yayoshi-Yamamoto et
al., 2000). These latter two reports suggest that the N-termini
of FH proteins are sufficient to interfere with migration,
possibly by inhibiting the respective endogenous FH protein.
We did not observe significant inhibition of migration upon
FHOD1 (1-421) expression. However, this fragment lacks the
GBD and thus might not block the appropriate signaling
pathways.
One novel aspect of our study is the long-term expression
Fig. 4. Dominant-negative Rac1 and inhibitors of
RhoA and ROCK block FHOD1 D C-dependent stress
fibers. (A) Rac1N17 blocks FHOD1- D C-dependent
stress fibers. NIH-3T3 cells were transiently
transfected with pCMV5-FHOD1 D C and pCMV-T7-
Rac1N17. FHOD1- and RacN17-expressing cells
were detected by in situ immunofluorescence. F-actin
was detected with phalloidin-rhodamine. (B) RhoA
activity is required for FHOD1-D C-dependent stress
fibers. FHOD1- D C-transfected NIH-3T3 cells were
incubated for 18 hours with 10 m M or 30 m M C3
transferase prior to in situ fluorescence analysis and
confocal microscopy. (C) ROCK activity is required
for FHOD1-D C-dependent stress fiber formation.
FHOD1-D C-transfected NIH-3T3 cells were
incubated for 10 minutes with 30 m M Y-27632.
FHOD1 D C and F-actin were detected with in situ
fluorescence and confocal microscopy.
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and analysis of a full-length FH protein. All previous studies
examining the roles of FH proteins in cell migration were
performed with fragments of the respective FH protein that
have not been identified in nature. Attempts to overexpress
Fmn and FRL were reportedly unsuccessful, leading the
investigators to conclude that stable expression of these FH
proteins is toxic (Vogt et al., 1993; Yayoshi-Yamamoto et al.,
2000). We were able to obtain long-term cultures of FHOD1-
overexpressing NIH-3T3 and WM35 cells. Our results might
be dependent on our choice of expression systems but it is
also possible that FHOD1 has a distinct role and that its
overexpression does not place the cells at a selective
disadvantage. Interestingly, our attempts to generate stable
FHOD1 D C expression were unsuccessful. The predominant
stress fibers found in cells transiently transfected with this
truncated and activated FHOD1 protein probably prohibit
long-term survival. These results suggest that individual
FH proteins might perform specialized functions and link
the actin cytoskeleton to different signaling pathways to
control cell activities.
FHOD1 was localized to cell membranes and
perinuclear regions in both stable and transient
transfectants (Fig. 1C, Fig. 3A). This staining pattern is
similar to that observed for mDia1 (Watanabe et al., 1997).
Interestingly, FHOD1 co-localized with F-actin in lamellae
but not with F-actin in the cytoplasm. These results
suggest that FHOD1 participates in filamentous actin
polymerization or nucleation at the cell membrane. The
induction of stress fiber formation in cells expressing an
activated FHOD1 protein lacking the C-terminal
autoregulatory domain has also been observed by others
(Oliver Fackler, personal communication) and indicates
that FHOD1 might have a role in actin polymerization.
These results agree well with the recent findings that FH
proteins in S. cerevisiae control cell polarity by nucleating
actin cable assembly independent of Arp2/3 proteins
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Fig. 5. FHOD1 expression does not affect cell adhesion. (A) FHOD1
expression does not significantly affect WM35 cell adhesion to type-I
collagen. WM35 cells were allowed to adhere to plates coated with
the indicated concentrations of type-I collagen for 20 minutes.
Adherent cells were quantified with a cell viability assay. The
number of adherent cells was normalized to a standard curve
generated by plating increasing numbers of cells. (B) FHOD1
expression does not significantly affect NIH-3T3 cell adhesion to
fibronectin. NIH-3T3 cells were allowed to adhere to plates coated
with the increasing concentrations of fibronectin for 20 minutes. The
number of adherent cells was determined as described in A.
Fig. 6. FHOD1 enhances cell migration. (A) Expression of full-
length FHOD1 in WM35 cells enhanced migration to type-I
collagen. The migration of control (MSCV) and FHOD1-
expressing WM35 cells to type-I collagen (1 m g ml–1 on the left,
indicated concentrations on the right) during a 4-5 hour period
was measured in a Boyden chamber. (B) Expression of full-
length FHOD1 in NIH-3T3 cells enhanced migration to
fibronectin, laminin and BCS. Each protein was used at a final
concentration of 1 m g ml–1. BCS was added at 10% (v/v). Cells
were allowed to migrate for 4-5 hours in a modified Boyden
chamber.
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(Evangelista et al., 2002; Pruyne et al., 2002; Sagot et al.,
2002). The nature of FHOD1 interactions with F-actin remains
to be determined. Full-length FHOD1 did interact with G-
protein monomers in vivo, but truncated FHOD1 proteins did
not. These data suggest that FHOD1 associates indirectly with
actin and/or that multiple regions of FHOD1 are necessary to
interact with actin or actin-binding proteins. One likely
candidate is profilin, which binds to the proline-rich FH1
domain of other FH proteins (Chang et al., 1997; Evangelista
et al., 1997; Umikawa et al., 1998; Watanabe et al., 1997;
Yayoshi-Yamamoto et al., 2000).
Many studies indicate that FH proteins are involved in actin
organization and the appearance of stress fibers. Truncated and
activated versions of mDia1, a downstream effector of RhoA
(Watanabe et al., 1997), induce thin actin stress fibers that are
subsequently organized into thick stress fibers by another
RhoA effector, ROCK (Watanabe et al., 1999). In this
report, we demonstrate that a truncated version of FHOD1
(residues 1-1010) also induces stress fibers. These actin
structures were inhibited by a dominant-negative Rac1
(N17) protein. The ROCK and RhoA inhibitors Y-27632
and C3 transferase also prevented stress fiber formation.
These data suggest that FHOD1 acts upstream of Rac1,
RhoA and ROCK. We previously placed Rac1 downstream
of FHOD1 in pathways activating transcription from the
SRE (Westendorf, 2001). Thus, there might exist multiple
classes of FH proteins, those that act upstream of Rho
family GTPases and those that are Rho GTPase effectors.
FHOD1 and Daam1, a Wnt-activated FH protein that regulates
RhoA (Habas et al., 2001), are members of the former class,
whereas mDia belongs in the latter. The signals that activate
FHOD1 remain to be identified. However, it is clear that FH
proteins have multiple, complex roles in the organization of
actin structures.
In summary, we found that FHOD1 co-localized with some
F-actin structures at the cell periphery. We also found that long-
term FHOD1 expression induced cell elongation and enhanced
migration of fibroblasts and melanomas cells. A FH gene (a
mDia2 homolog) was identified as being overexpressed
differently in highly metastatic rat osteosarcoma cells (Fukuda
et al., 1999). Thus, increased FH protein expression might play
a role in tumor metastasis by facilitating actin polymerization.
Subsequent stabilization of actin filaments would lead to the
formation of contractile bundles that are important for cell
motility (Feldner and Brandt, 2002). Our data indicate that
FHOD1 expression increases migration without altering
integrin expression, affinity or avidity. Future studies will
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Fig. 7. FHOD1 expression does not affect integrin expression or
use. (A) FHOD1 does not significantly alter integrin expression
on WM35 cells. Stable WM35 cells were incubated with PE-
conjugated anti-integrin antibodies and analyzed by flow
cytometry. The mean PE fluorescence intensity of eGFP-positive
cells was determined with CellQuest software. (B) FHOD1
expression does not alter integrin usage during cell adhesion.
Cells were preincubated for 20 minutes with 2.5 m g ml–1 of the
isotype-matched control or the indicated a -integrin mAb, or with
1 m g ml–1 of anti-b 1 mAb. The amount of cell adhesion to plates
coated with 15 m g ml–1 type-I collagen within 20 minutes was
determined with a cell viability assay. Values for each cell line
were normalized to the control cells incubated with the isotype-
matched mAb. (C) FHOD1 does not alter integrin usage during
cell migration. WM35-MSCV control (left) or FHOD1-
expressing (right) cells were preincubated for 20 minutes with
2.5 m g ml–1 of the isotype-matched control or the indicated a -
integrin mAb or with 1 m g ml–1 of anti-b 1 mAb. Cell migration
during a 4.5 hour period was measured in a modified Boyden
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Fig. 8. FHOD1 expression does not affect b 1-integrin activation.
MSCV and FHOD1-expressing WM35 cells were incubated with
antibodies recognizing the b 1-integrin activation epitopes15/7 and
9EG7, the pan- b 1-integrin epitope P5D2 or control IgG for 30
minutes on ice followed by a 30-minute incubation with a Cy5-
conjugated secondary mAb. Mean fluorescent intensities of eGFP-
positive cells were determined with CellQuest software and
normalized to baseline levels of control antibodies.
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address the roles of FHOD1 in regulating events downstream
of integrins to better understand its role in cell motility and
potentially tumor metastasis.
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